ESTA Company Profile and Key Details

Short-term trend indicators are bearishly aligned (SMA20 5.56%, SMA50 8.34%, SMA200 48.14%). The stock’s 14-day RSI is 60.14 (firm momentum), while the ATR of 4.87 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -7.39% below its high and over 190.53% above its low. Average 10-day trading volume of 563.34 thousand shares is slightly above the 3-month average of 492.54 thousand, indicating heightened recent market interest.

Establishment Labs Holdings Inc. (NASDAQ:ESTA) closed at $85.11 USD, gaining $5.65 (7.11%) from the previous close of $79.46. The stock is currently trading near its 52-week high $33.35 and $85.56. With a market capitalization of about $2.50 billion, Establishment Labs Holdings Inc. is classified as a mid-cap and shows market-like volatility (beta ~1.11). Key stats such as the average daily volume over the past year has been around 498.25 thousand shares, in line with its 52-week average. Headquartered in Alajuela, None, Establishment Labs Holdings Inc. operates in the Healthcare sector and the Medical - Devices industry. Led by CEO Fillipo Peter Caldini, the company employs approximately 1,034 people and listed since July 19, 2018. Establishment Labs Holdings Inc. operates as a medical technology enterprise specializing in the creation and commercialization of devices for aesthetic and reconstructive plastic surgery.

Establishment Labs Holdings Inc. trades at a P/E ratio of -57.27, slightly below the S&P 500 average, with a price-to-sales ratio of 10.84 and a price-to-book ratio of 169.44 reflecting a rich premium to book value. The P/FCF stands at -59.09, also below market averages. Compared to sector medians, Establishment Labs Holdings Inc. P/S is trading rich, and the P/B is far higher than peers, underscoring the brand and earnings power premium investors assign to the stock.

Establishment Labs Holdings Inc. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around -$77.66. This means the shares are trading below this model’s fair value.

Establishment Labs Holdings Inc. generated EPS of -$1.74 over the past year. Five-year average earnings growth is -1.07%. The latest quarter delivered EPS of -$0.45. The next quarter is forecast at -$0.34. Next year's EPS is expected at $39.64. Analyst sentiment is bullish. Analyst rating data shows there are 7 Strong Buy ratings, 15 Buy ratings, 3 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $100.00 to $47.00. The high target offers 17.5% upside. The low target suggests -44.78% downside. The mean target is $78.84. This offers -7.37% upside. Establishment Labs Holdings Inc. earnings surprise history is a mixed track record. The quarter that ended May 06, 2026, missed forecasts by 26.78%. The prior quarter beat by -58.14%. Over the last six quarters, Apple has recorded several small beats. These include 53.12% in February 26, 2025.

Establishment Labs Holdings Inc. has 28.97 million shares outstanding. The public float is 16.95 million shares, elevated short interest at 24.14% of float. This equals 4.76 million shares. The short ratio is 14.57 days. Institutional investors hold 117.35% of the float. Insiders own 10.74%. Wild Jason G. holds 3.19 million shares, JW Asset Management, LLC has 2.89 million shares and Chacon Quiros Juan Jose has 927.50 thousand shares. Over the past six months, insider transactions show net selling. They sold 258.40 thousand shares across 15 transactions.

Our AI price prediction model suggests that Establishment Labs Holdings Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected increase of 0.83%, with price expected at $85.82 by June 25, 2026, within a range of $82.41 to $89.33 3-Month Outlook: Projected rise of 17.89%, reaching $100.34 by September 08, 2026, with a range of $97.06 to $104.38. 1-Year Outlook: Projected loss of -1.59%, with price at $83.76 by June 11, 2027, within a range of $78.61 to $89.05.

Establishment Labs Holdings Inc. (NASDAQ:ESTA) shares are down -11.32% year-to-date currently trading near 52-week highs band. Short-term momentum has been positive over the last quarter, despite recent volatility. Valuation shows Establishment Labs Holdings Inc. trading at a premium to the broader market with a P/E of -57.27. Analyst sentiment is bullish, with the majority of ratings in Buy territory and a mean price target of $73.10, suggesting -14.11% downside. Our AI forecast model points to short-term strength (0.83% over two weeks), a medium-term rise (17.89% over three months), and a longer-term loss (-1.59% over one year), with expected trading ranges indicating moderate volatility.